Goldman Sachs Invests $37M In Venture-Backed Venus Medtech

Goldman Sachs has agreed to invest US$37 million in Venus Medtech, a Hangzhou-based healthcare company focused on research and development of heart valves disease related medical products and services, according to a company announcement. At the same time, Venus Medtech says it has jointly established a heart valves research center in Hangzhou with the Second […]


Visit ChinaMoneyNetwork.com for more daily finance news, including audio and video Internet podcasts covering important investment news and financial events in China. Follow us on Twitter @chinamoneypod subscribe to all episodes on iTunes.

Read the original article: China Money Network